Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 25 December, 2024
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 531380 | NSE: CSURGSU

Centenial Surgical Suture Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 24, 2024, 12:32 pm

Market Cap 50.0 Cr.
Current Price 137
High / Low 170/84.0
Stock P/E53.8
Book Value 89.5
Dividend Yield0.00 %
ROCE8.07 %
ROE3.57 %
Face Value 10.0
PEG Ratio33.22

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Centenial Surgical Suture Ltd

Competitors of

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Constronics Infra Ltd 143 Cr. 114 158/14.777.2 22.90.00 %20.8 %118 % 10.0
Centenial Surgical Suture Ltd 50.0 Cr. 137 170/84.053.8 89.50.00 %8.07 %3.57 % 10.0
Adeshwar Meditex Ltd 33.2 Cr. 23.0 36.0/20.015.2 24.80.00 %9.62 %5.93 % 10.0
Poly Medicure Ltd 25,664 Cr. 2,529 3,358/1,36187.0 2560.12 %23.6 %19.1 % 5.00
Mohini Health & Hygiene Ltd 92.4 Cr. 50.6 70.9/46.08.86 57.20.99 %14.5 %11.1 % 10.0
Industry Average12,903.50 Cr570.7248.4190.080.22%15.32%31.54%9.00

All Competitor Stocks of

Quarterly Result

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales8.3711.9312.3711.7513.4913.0113.1313.0213.6613.1012.3812.0513.74
Expenses7.4510.7311.1810.6112.3811.9812.0611.9212.5011.9611.1910.5412.02
Operating Profit0.921.201.191.141.111.031.071.101.161.141.191.511.72
OPM %10.99%10.06%9.62%9.70%8.23%7.92%8.15%8.45%8.49%8.70%9.61%12.53%12.52%
Other Income0.000.000.000.040.000.080.020.030.010.020.060.030.00
Interest0.450.460.460.520.370.390.390.520.480.520.510.950.53
Depreciation0.370.410.390.370.340.310.340.310.300.320.330.440.79
Profit before tax0.100.330.340.290.400.410.360.300.390.320.410.150.40
Tax %30.00%27.27%32.35%68.97%25.00%26.83%22.22%53.33%25.64%28.12%24.39%-26.67%25.00%
Net Profit0.080.250.230.080.300.300.280.140.290.240.310.190.30
EPS in Rs0.220.690.630.220.820.820.770.380.790.660.850.520.82

Last Updated: October 7, 2024, 8:24 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: September 23, 2024, 2:47 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales54.0050.9651.7151.3952.8452.7356.0555.6136.9344.4352.6651.1951.27
Expenses49.1546.3946.4746.7147.9548.2650.6449.6831.8239.9448.2646.0445.71
Operating Profit4.854.575.244.684.894.475.415.935.114.494.405.155.56
OPM %8.98%8.97%10.13%9.11%9.25%8.48%9.65%10.66%13.84%10.11%8.36%10.06%10.84%
Other Income0.020.040.100.020.010.050.020.090.090.040.130.130.11
Interest1.701.311.611.651.771.511.892.312.121.931.772.622.51
Depreciation0.580.590.830.680.590.600.691.551.551.531.301.391.88
Profit before tax2.592.712.902.372.542.412.852.161.531.071.461.271.28
Tax %39.38%33.95%34.14%34.18%32.68%36.10%29.12%39.81%37.25%42.06%39.73%11.02%
Net Profit1.571.791.921.561.721.542.021.300.960.630.891.131.04
EPS in Rs4.304.915.264.284.714.225.543.562.631.732.443.102.85
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)14.01%7.26%-18.75%10.26%-10.47%31.17%-35.64%-26.15%-34.38%41.27%26.97%
Change in YoY Net Profit Growth (%)0.00%-6.75%-26.01%29.01%-20.72%41.63%-66.81%9.49%-8.22%75.64%-14.30%

Centenial Surgical Suture Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:0%
5 Years:-2%
3 Years:12%
TTM:-1%
Compounded Profit Growth
10 Years:-5%
5 Years:-11%
3 Years:6%
TTM:-2%
Stock Price CAGR
10 Years:17%
5 Years:33%
3 Years:38%
1 Year:33%
Return on Equity
10 Years:5%
5 Years:3%
3 Years:3%
Last Year:4%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:00 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital5.425.425.425.425.425.425.425.425.425.425.425.425.42
Reserves12.0413.8315.7917.3519.0720.6222.6323.1824.1524.7725.6626.7927.22
Borrowings12.6511.3212.2813.1115.2414.3713.1012.7213.479.309.9223.240.00
Other Liabilities17.6319.5321.8016.6816.0714.8915.6127.9627.0021.8525.4023.7054.43
Total Liabilities47.7450.1055.2952.5655.8055.3056.7669.2870.0461.3466.4079.1587.07
Fixed Assets4.724.534.133.643.713.804.0810.448.977.606.4612.7720.77
CWIP0.190.190.190.190.190.220.220.220.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets42.8345.3850.9748.7351.9051.2852.4658.6261.0753.7459.9466.3866.30
Total Assets47.7450.1055.2952.5655.8055.3056.7669.2870.0461.3466.4079.1587.07

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +0.63-0.250.21-1.510.001.761.552.081.974.751.306.21
Cash from Investing Activity +-0.53-0.42-0.36-0.19-2.38-0.64-1.02-1.31-0.89-0.17-0.18-7.92
Cash from Financing Activity +2.24-1.340.960.822.14-0.88-1.27-0.37-1.27-4.87-1.052.06
Net Cash Flow2.34-2.010.80-0.88-0.250.24-0.750.40-0.18-0.280.070.35

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-7.80-6.75-7.04-8.43-10.35-9.90-7.69-6.79-8.36-4.81-5.52-18.09

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days127.89135.08138.21132.75130.76125.29134.80153.26221.39160.44142.71134.05
Inventory Days218.51297.67350.07365.93468.59465.89434.68483.861,276.44599.23677.26909.72
Days Payable144.77162.36167.34124.26146.28135.64120.26187.98372.75159.00222.42207.75
Cash Conversion Cycle201.63270.39320.94374.42453.06455.54449.22449.141,125.08600.67597.56836.02
Working Capital Days159.45187.94205.48233.39156.25164.05167.69172.36403.64313.08276.49329.63
ROCE %15.21%13.25%14.08%11.59%11.40%9.78%11.62%10.84%8.65%7.27%8.03%8.07%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters44.78%44.78%44.78%44.78%44.78%44.78%45.48%46.89%46.89%46.89%46.89%46.89%
Public55.22%55.22%55.22%55.22%55.22%55.22%54.52%53.12%53.12%53.12%53.12%53.12%
No. of Shareholders7998678878889009118959009471,0161,0721,159

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)3.112.431.722.643.55
Diluted EPS (Rs.)3.112.431.722.643.55
Cash EPS (Rs.)4.654.033.974.635.25
Book Value[Excl.RevalReserv]/Share (Rs.)59.4057.3155.6754.5252.74
Book Value[Incl.RevalReserv]/Share (Rs.)59.4057.3155.6754.5252.74
Revenue From Operations / Share (Rs.)94.3797.0781.9068.09102.53
PBDIT / Share (Rs.)9.468.168.289.4010.86
PBIT / Share (Rs.)6.905.765.476.548.00
PBT / Share (Rs.)2.352.701.982.823.97
Net Profit / Share (Rs.)2.091.631.161.772.39
PBDIT Margin (%)10.028.4010.1113.8010.59
PBIT Margin (%)7.305.936.679.607.80
PBT Margin (%)2.482.772.414.143.87
Net Profit Margin (%)2.211.681.412.602.33
Return on Networth / Equity (%)3.522.852.073.254.52
Return on Capital Employeed (%)8.088.378.009.2011.31
Return On Assets (%)1.431.331.021.371.87
Total Debt / Equity (X)0.440.310.300.410.00
Asset Turnover Ratio (%)0.700.820.670.530.88
Current Ratio (X)1.992.042.201.921.87
Quick Ratio (X)0.690.760.860.770.83
Inventory Turnover Ratio (X)0.500.580.450.460.79
Interest Coverage Ratio (X)2.082.662.372.532.70
Interest Coverage Ratio (Post Tax) (X)1.461.531.331.481.59
Enterprise Value (Cr.)63.3143.0441.9934.9218.15
EV / Net Operating Revenue (X)1.240.810.940.940.32
EV / EBITDA (X)12.349.729.356.853.08
MarketCap / Net Operating Revenue (X)0.960.630.740.620.33
Price / BV (X)1.541.081.090.780.65
Price / Net Operating Revenue (X)0.960.630.740.620.33
EarningsYield0.020.020.010.040.06

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Centenial Surgical Suture Ltd as of December 25, 2024 is: 175.34

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 25, 2024, Centenial Surgical Suture Ltd is Undervalued by 27.99% compared to the current share price 137.00

Intrinsic Value of Centenial Surgical Suture Ltd as of December 25, 2024 is: 178.18

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 25, 2024, Centenial Surgical Suture Ltd is Undervalued by 30.06% compared to the current share price 137.00

Last 5 Year EPS CAGR: 1.62%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (21.01 cr) compared to borrowings (12.36 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (50.91 cr) and profit (2.09 cr) over the years.
  1. The stock has a low average ROCE of 10.82%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 230.79, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 417.47, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Centenial Surgical Suture Ltd:
    1. Net Profit Margin: 2.21%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 8.08% (Industry Average ROCE: 15.32%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 3.52% (Industry Average ROE: 31.54%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 1.46
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.69
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 53.8 (Industry average Stock P/E: 48.41)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.44
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Centenial Surgical Suture Ltd. is a Public Limited Listed company incorporated on 20/06/1995 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1995PLC089759 and registration number is 089759. Currently Company is involved in the business activities of Manufacture of medical impregnated wadding, gauze, bandages, dressings, surgical gut string etc.. Company’s Total Operating Revenue is Rs. 44.43 Cr. and Equity Capital is Rs. 5.42 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Medical Equipment & AccessoriesF-29, MIDC, Murbad Thane Maharashtra 421401admin@centenialindia.com
http://www.centenialindia.com
Management
NamePosition Held
Mr. Vijay MajrekarManaging Director & CEO
Ms. Anuradha KashikarExecutive Director & CFO
Mr. Devraj T PoojaryExecutive Director
Mr. Neel M VoraInd. Non-Executive Director
Mr. Ridhima B LimayeInd. Non-Executive Director
Mr. Akash S ModiInd. Non-Executive Director
Mr. Anuj V ShahInd. Non-Executive Director

FAQ

What is the latest intrinsic value of Centenial Surgical Suture Ltd?

The latest intrinsic value of Centenial Surgical Suture Ltd as on 25 December 2024 is ₹175.34, which is 27.99% higher than the current market price of ₹137.00. The stock has a market capitalization of 50.0 Cr. and recorded a high/low of 170/84.0 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹27.22 Cr and total liabilities of ₹87.07 Cr.

What is the Market Cap of Centenial Surgical Suture Ltd?

The Market Cap of Centenial Surgical Suture Ltd is 50.0 Cr..

What is the current Stock Price of Centenial Surgical Suture Ltd as on 25 December 2024?

The current stock price of Centenial Surgical Suture Ltd as on 25 December 2024 is 137.

What is the High / Low of Centenial Surgical Suture Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Centenial Surgical Suture Ltd stocks is 170/84.0.

What is the Stock P/E of Centenial Surgical Suture Ltd?

The Stock P/E of Centenial Surgical Suture Ltd is 53.8.

What is the Book Value of Centenial Surgical Suture Ltd?

The Book Value of Centenial Surgical Suture Ltd is 89.5.

What is the Dividend Yield of Centenial Surgical Suture Ltd?

The Dividend Yield of Centenial Surgical Suture Ltd is 0.00 %.

What is the ROCE of Centenial Surgical Suture Ltd?

The ROCE of Centenial Surgical Suture Ltd is 8.07 %.

What is the ROE of Centenial Surgical Suture Ltd?

The ROE of Centenial Surgical Suture Ltd is 3.57 %.

What is the Face Value of Centenial Surgical Suture Ltd?

The Face Value of Centenial Surgical Suture Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Centenial Surgical Suture Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE